Format

Send to

Choose Destination
BMC Cancer. 2015 Feb 19;15:1. doi: 10.1186/1471-2407-15-1.

Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway.

Author information

1
Cancer Research Institute, Southern Medical University, Guangzhou 510, 515, Guangdong Province, People's Republic of China. tianyunhong1985@163.com.
2
Department of Radiation Oncology, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. tianyunhong1985@163.com.
3
Department of Oncology, Armed Police Corps Hospital of Guangdong Province, Guangzhou, People's Republic of China. 327231131@qq.com.
4
Cancer Research Institute, Southern Medical University, Guangzhou 510, 515, Guangdong Province, People's Republic of China. 497336449@qq.com.
5
Cancer Research Institute, Southern Medical University, Guangzhou 510, 515, Guangdong Province, People's Republic of China. 273733970@qq.com.
6
Department of Oncology, Armed Police Corps Hospital of Guangdong Province, Guangzhou, People's Republic of China. 731704102@qq.com.
7
Department of Oncology, Armed Police Corps Hospital of Guangdong Province, Guangzhou, People's Republic of China. 2536941857@qq.com.
8
Department of Oncology, Armed Police Corps Hospital of Guangdong Province, Guangzhou, People's Republic of China. 1165736760@qq.com.
9
Cancer Research Institute, Southern Medical University, Guangzhou 510, 515, Guangdong Province, People's Republic of China. 2224035596@qq.com.
10
Department of Oncology, Armed Police Corps Hospital of Guangdong Province, Guangzhou, People's Republic of China. 335616703@qq.com.
11
Cancer Research Institute, Southern Medical University, Guangzhou 510, 515, Guangdong Province, People's Republic of China. yao.kaitai@yahoo.cn.

Abstract

BACKGROUND:

Glioblastoma multiforme (GBM) is the most common primary central nervous system neoplasm in adults. Radioactive (125)I seed implantation has been widely applied in the treatment of cancers. Moreover, previous clinical trials have confirmed that (125)I seeds treatment was an effective therapy in GBM. We sought to investigate the effect of (125)I seed on GBM cell growth and Epithelial-mesenchymal transition (EMT).

METHODS:

Cells were exposed to irradiation at different doses. Colony-formation assay, EdU assay, cell cycle analysis, and TUNEL assay were preformed to investigate the radiation sensitivity. The effects of (125)I seeds irradiation on EMT were measured by transwell, Boyden and wound-healing assays. The levels of reactive oxygen species (ROS) were measured by DCF-DA assay. Moreover, the radiation sensitivity and EMT were investigated with or without pretreatment with glutathione. Additionally, nude mice with tumors were measured after treated with radiation.

RESULTS:

Radioactive (125)I seeds are more effective than X-ray irradiation in inhibiting GBM cell growth. Moreover, EMT was effectively inhibited by (125)I seed irradiation. A mechanism study indicated that GBM cell growth and EMT inhibition were induced by (125)I seeds with the involvement of a ROS-mediated signaling pathway.

CONCLUSIONS:

Radioactive (125)I seeds exhibit novel anticancer activity via a ROS-mediated signaling pathway. These findings have clinical implications for the treatment of patients with GBM by (125)I seeds.

PMID:
25971837
PMCID:
PMC4429713
DOI:
10.1186/1471-2407-15-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center